Revolution Medicines Retained Earnings (Accumulated Deficit) 2018-2024 | RVMD
Revolution Medicines retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-1.387B, a 59.83% increase year-over-year.
- Revolution Medicines retained earnings (accumulated deficit) for 2023 were $-1.138B, a 62.22% increase from 2022.
- Revolution Medicines retained earnings (accumulated deficit) for 2022 were $-0.701B, a 54.95% increase from 2021.
- Revolution Medicines retained earnings (accumulated deficit) for 2021 were $-0.453B, a 70.46% increase from 2020.